Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Protein transduction by poly-arginine].

Hideki Matsui1, Kazuhito Tomizawa, Masayuki Matsushita

  • 1Department of Physiology, Okayama University, Graduate School of Medicine and Dentistry, Japan. matsuihi@cc.okayama-u.ac.jp

Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|July 2, 2003
PubMed
Summary

Researchers developed a novel, high-efficiency protein transduction domain (PTD) using 11 arginine residues. This new PTD effectively delivers therapeutic proteins and bioactive compounds into eukaryotic cells for potential treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CDKAL1 dysfunction impairs lysine codon translation in podocytes and accelerates chronic kidney disease.

The EMBO journal·2026
Same author

TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn<sup>2+</sup> Homeostasis.

Circulation·2026
Same author

Monitoring the complexity and dynamics of mitochondrial translation.

Molecular cell·2025
Same author

Mitochonic acid 5 mitigates age-related hearing loss progression by targeting defective 2-methylthiolation in mitochondrial transfer RNAs.

Frontiers in cellular neuroscience·2025
Same author

Mg<sup>2+</sup> influx mediated by TRPM7 triggers the initiation of muscle stem cell activation.

Science advances·2025
Same author

Neurological Diseases Caused by Loss of Transfer RNA Modifications: Commonalities in Their Molecular Pathogenesis.

Journal of molecular biology·2025

Area of Science:

  • Cell biology
  • Molecular biology
  • Biochemistry

Context:

  • Protein transduction domains (PTDs) facilitate the intracellular delivery of proteins and peptides.
  • Initial PTDs were derived from viral or homeoprotein sequences like HIV-1 TAT, HSV VP-22, and antennapedia.
  • Developing efficient and novel PTDs is crucial for advancing protein-based therapeutics.

Purpose:

  • To engineer a novel, high-efficiency protein transduction domain (PTD).
  • To utilize the PTD for regulating intracellular signal cascades.
  • To establish a versatile platform for delivering therapeutic proteins and bioactive compounds.

Summary:

  • A novel PTD, designated 11R, was developed based on the HIV-1 TAT sequence, incorporating 11 arginine residues for enhanced efficiency.

Related Experiment Videos

  • The 11R PTD demonstrated effectiveness in delivering proteins and other bioactive molecules into eukaryotic cells.
  • This PTD was successfully employed to regulate intracellular signal cascades, showcasing its functional utility.

    • Impact:

    • The development of the 11R PTD offers a promising strategy for enhancing the delivery of protein-based therapeutics.
    • This technology has the potential to improve the efficacy of treatments targeting intracellular pathways.
    • The 11R PTD serves as a valuable tool for drug delivery and the development of novel therapeutic agents.